Allos Therapeutics Inc. (ALTH) surged 27 percent to $1.82. The biopharmaceutical company agreed to be bought by Spectrum Pharmaceuticals Inc. (SPPI) for $1.82 a share, plus rights worth 11 cents a share tied to European regulatory approval and sales of its Folotyn cancer drug. Spectrum declined 14 percent to $10.40.
AngioDynamics Inc. (ANGO) : The maker of devices to treat cancer and heart disease forecast fourth-quarter earnings may be as low as 9 cents a share, compared with the average analyst estimate of 11 cents.
Bed Bath & Beyond Inc. (BBBY) rose 4.6 percent to $69.28. The retail-chain operator posted a fourth-quarter profit of $1.48 a share, beating the average analyst estimate of $1.32.
Galena Biopharma Inc. (GALE) slid 16 percent to $1.57. The developer of late-stage oncology drugs said it plans to sell stock to raise working capital and fund clinical trials.
Pandora Media Inc. (P) : The Internet radio pioneer is in a pact with Nissan Motor Co. (7201)(7201 JP) to allow for in-car streaming in the auto company’s 2013 Altima. Suzuki Motor Corp. (7269) (7269 JP) will also integrate Pandora into its vehicles.
Polycom Inc. (PLCM) dropped 16 percent to $10.47. The maker of videoconference systems forecast first-quarter earnings of 23 cents a share at most, missing the average analyst estimate of 30 cents a share.
PriceSmart Inc. (PSMT) : The owner of warehouse-shopping clubs reported second-quarter earnings were 67 cents a share, trailing analysts’ average estimate by 1 cent.
Ruby Tuesday Inc. (RT) slid 12 percent to $7.85. The casual-dining chain forecast same store sales may fall 4.5 percent in 2012.
Zumiez Inc. (ZUMZ) : The sports-apparel retailer said comparable store sales increased 14 percent in March, exceeding the average analyst estimate of 10 percent.
If you enjoy the content at iBankCoin, please follow us on Twitter
